191 related articles for article (PubMed ID: 24933972)
1. [Serotonin levels and short chain fatty acids in pathogenesis of irritable bowel syndrome].
Dorofeev AÉ; Ardatskaia MD; Rassokhina OA; Kir'ian EA; Konovalova TA; Tarasova VI
Eksp Klin Gastroenterol; 2013; (11):10-4. PubMed ID: 24933972
[TBL] [Abstract][Full Text] [Related]
2. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C
Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
[TBL] [Abstract][Full Text] [Related]
3. Serum fatty acid profile in subjects with irritable bowel syndrome.
Solakivi T; Kaukinen K; Kunnas T; Lehtimäki T; Mäki M; Nikkari ST
Scand J Gastroenterol; 2011 Mar; 46(3):299-303. PubMed ID: 21073373
[TBL] [Abstract][Full Text] [Related]
4. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
[TBL] [Abstract][Full Text] [Related]
5. Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model.
O'Mahony S; Chua AS; Quigley EM; Clarke G; Shanahan F; Keeling PW; Dinan TG
Neurogastroenterol Motil; 2008 Jun; 20(6):680-8. PubMed ID: 18194152
[TBL] [Abstract][Full Text] [Related]
6. Decreased levels of kynurenic acid in the intestinal mucosa of IBS patients: relation to serotonin and psychological state.
Keszthelyi D; Troost FJ; Jonkers DM; Kruimel JW; Leue C; Masclee AA
J Psychosom Res; 2013 Jun; 74(6):501-4. PubMed ID: 23731747
[TBL] [Abstract][Full Text] [Related]
7. Sigmoid-colonic motility in health and irritable bowel syndrome: a role for 5-hydroxytryptamine.
Houghton LA; Atkinson W; Lockhart C; Whorwell PJ; Keevil B
Neurogastroenterol Motil; 2007 Sep; 19(9):724-31. PubMed ID: 17539895
[TBL] [Abstract][Full Text] [Related]
8. Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome.
Christmas DM; Badawy AA; Hince D; Davies SJ; Probert C; Creed T; Smithson J; Afzal M; Nutt DJ; Potokar JP
Nutr Res; 2010 Oct; 30(10):678-88. PubMed ID: 21056283
[TBL] [Abstract][Full Text] [Related]
9. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
Kerckhoffs AP; Ter Linde JJ; Akkermans LM; Samsom M
Neurogastroenterol Motil; 2008 Aug; 20(8):900-7. PubMed ID: 18363639
[TBL] [Abstract][Full Text] [Related]
10. Mast cells count and serum cytokine levels in patients with irritable bowel syndrome.
Goral V; Kucukoner M; Buyukbayram H
Hepatogastroenterology; 2010; 57(101):751-4. PubMed ID: 21033222
[TBL] [Abstract][Full Text] [Related]
11. Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut?
Camilleri M
J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S46-8. PubMed ID: 19300123
[TBL] [Abstract][Full Text] [Related]
12. Correlation of gut hormones with irritable bowel syndrome.
Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L
Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690
[TBL] [Abstract][Full Text] [Related]
13. 5-hydroxytryptamine signalling in irritable bowel syndrome with diarrhoea: effects of gender and menstrual status.
Houghton LA; Brown H; Atkinson W; Morris J; Fell C; Whorwell PJ; Lockhart S; Keevil B
Aliment Pharmacol Ther; 2009 Nov; 30(9):919-29. PubMed ID: 19691669
[TBL] [Abstract][Full Text] [Related]
14. Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis.
Luo M; Zhuang X; Tian Z; Xiong L
BMC Gastroenterol; 2021 Jan; 21(1):14. PubMed ID: 33407171
[TBL] [Abstract][Full Text] [Related]
15. Proximal and distal gut hormone secretion in irritable bowel syndrome.
Van Der Veek PP; Biemond I; Masclee AA
Scand J Gastroenterol; 2006 Feb; 41(2):170-7. PubMed ID: 16484122
[TBL] [Abstract][Full Text] [Related]
16. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
Atkinson W; Lockhart S; Whorwell PJ; Keevil B; Houghton LA
Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466
[TBL] [Abstract][Full Text] [Related]
17. Decreased Basal and postprandial plasma serotonin levels in patients with functional dyspepsia.
Cheung CK; Lee YY; Chan Y; Cheong PK; Law WT; Lee SF; Sung JJ; Chan FK; Wu JC
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1125-9. PubMed ID: 23591288
[TBL] [Abstract][Full Text] [Related]
18. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
[TBL] [Abstract][Full Text] [Related]
19. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
20. [Serotonin transporter gene polymorphisms in irritable bowel syndrome and their impact on tegaserod treatment].
Li YY; Nie YQ; Xie J; Tan HZ; Zhou YJ; Wang H
Zhonghua Nei Ke Za Zhi; 2006 Jul; 45(7):552-5. PubMed ID: 17074108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
